Company news

OncoSil Medical Ltd news in 2018

OncoSil Medical Ltd's news releases, calls and decks from 2018, newest first.

View company

PanCo Study Interim Analysis

October 24, 2018

R&D Refund - 2018 Financial Year

September 24, 2018

IQVIA appointed EU Market Access and Reimbursement Advisor

August 29, 2018

Preliminary Final Report

August 22, 2018

Appendix 4C & Quarterly Update

July 25, 2018

Response to Price Query

May 31, 2018

Oncosil submits Clinical Study Report to Notified Body

May 13, 2018

Clinical Programme Update

April 4, 2018

Oncosil Medical Share Purchase Plan

March 27, 2018

Successful Completion of Capital Raising

March 22, 2018

Presentation-Surgical Resection Outcomes and Capital Raising

March 20, 2018

Positive Early Study Results Continue

February 27, 2018

Appendix 4D & Half Yearly Report and Accounts

February 21, 2018

First Subject Recruited in the United States

February 7, 2018

Additional Receipt of $0.6m R&D Tax Incentive Refund

January 16, 2018

Appendix 3C - Employee Loan Share Buy Back

January 10, 2018

Decks in 2018